Fertility clinics said to lack regulation
By United Press International,
United Press International [cites Marcy Darnovsky]
| 03. 02. 2009
The birth of octuplets in California calls attention to a lack of regulation in the field of assisted reproduction, some experts said.
Although the doctor who supervised in vitro fertilization on the 33-year-old woman who gave birth to octuplets in January is regarded by many in the field as having violated professional norms, U.S. health records indicate a large majority of fertility clinics disregarded implant guidelines in 2006, the Oakland (Calif.) Tribune reported Sunday.
Citing data from the U.S. Centers for Disease Control and Prevention, the newspaper said 80 percent of U.S. fertility clinics in 2006 -- the most recent year for which records are available -- did not follow embryo implant guidelines set in 1999 by the American Society for Reproductive Medicine. The organization advises implanting no more than two embryos in women younger than 35, the report said.
"Assisted reproduction is a multibillion-dollar business," Marcy Darnovsky of the Center for Genetics and Society in Oakland said. "Like other commercial enterprises, it needs rules."
ASRM spokesman Sean Tipton told the newspaper exceptions to the guidelines are permitted, and the...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...